BRENTUXIMAB VEDOTIN

10402 reported adverse events

Drug classes: CD30-directed Immunoconjugate [EPC]

These side effects are most commonly reported by patients taking BRENTUXIMAB VEDOTIN:

# Side effect Count
0 OFF LABEL USE 1358
1 FEBRILE NEUTROPENIA 776
2 NEUROPATHY PERIPHERAL 725
3 PYREXIA 694
4 NEUTROPENIA 599
5 DEATH 594
6 HODGKIN^S DISEASE 462
7 NAUSEA 407
8 ANAEMIA 399
9 THROMBOCYTOPENIA 388
See all common reactions for BRENTUXIMAB VEDOTIN

BRENTUXIMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT 15 0.5357
1 ADRENAL INFARCTION 14 0.5000
2 ANAPLASTIC LARGE-CELL LYMPHOMA 86 0.3644
3 HAEMATOPOIETIC STEM CELL MOBILISATION 17 0.2656
4 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 64 0.2184
5 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 92 0.1551
6 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 35 0.1115
7 CANCER FATIGUE 16 0.0672
8 LARYNGEAL DYSPNOEA 14 0.0611
9 CONGENITAL APLASIA 19 0.0611
See all enriched reactions for BRENTUXIMAB VEDOTIN